0001140361-16-087794.txt : 20161123 0001140361-16-087794.hdr.sgml : 20161123 20161123164200 ACCESSION NUMBER: 0001140361-16-087794 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161121 FILED AS OF DATE: 20161123 DATE AS OF CHANGE: 20161123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 162017083 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 doc1.xml FORM 4 X0306 4 2016-11-21 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2016-11-21 2016-11-21 4 M 0 69744 26.490 A 240426 D Common Stock 2016-11-21 2016-11-21 4 S 0 69744 87.5556 D 170682 D Common Stock 2016-11-22 2016-11-22 4 M 0 69743 26.490 A 240425 D Common Stock 2016-11-22 2016-11-22 4 S 0 69743 85.6934 D 170682 D Common Stock 182801 I Shares held by Jean-Jacques Bienaime Family Trust Stock Option (right to buy Common Stock) 26.49 2016-11-21 2016-11-21 4 M 0 69744 0 D 2011-11-12 2021-05-11 Common Stock 69744 210256 D Stock Option (right to buy Common Stock) 26.49 2016-11-22 2016-11-22 4 M 0 69743 0 D 2011-11-12 2021-05-11 Common Stock 69743 140513 D Trade made pursuant to a 10b5-1 plan executed on June 9, 2016. Mr. Bienaime's former spouse will receive the net proceeds from the shares sold in this transaction in connection with cash payments owed to her pursuant to a marital separation agreement between her and Mr. Bienaime. The amount of securities beneficially owned has been updated from the reporting person's prior Form 4 to reflect (a) changes in the form of ownership due to transfers made by the reporting person between accounts held directly and indirectly in the name of the Bienaime Family Trust and the Jean-Jacques Bienaime Family Trust and (b) an additional 4,357 shares beneficially owned by the reporting person pursuant to a reconciliation of the Company's records following the completion of the transfer of shares in connection with the reporting person's marital separation agreement. The price in column 4 is the weighted average price. The price actually received ranged from $86.74 to $89.59. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. The price in column 4 is the weighted average price. The price actually received ranged from $84.45 to $88.16. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. Reflects the number of stock options outstanding after the transaction from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2016-11-23